Get the Stockscreener App
24.88
0.77%
0.19
Progyny Inc stock is traded at $24.88, with a volume of 1.43M.
It is up +0.77% in the last 24 hours and up +38.30% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$24.69
Open:
$24.73
24h Volume:
1.43M
Relative Volume:
0.90
Market Cap:
$1.95B
Revenue:
$1.29B
Net Income/Loss:
$58.52M
P/E Ratio:
38.11
EPS:
0.6528
Net Cash Flow:
$191.78M
1W Performance:
+7.01%
1M Performance:
+38.30%
6M Performance:
-3.79%
1Y Performance:
+19.10%
1-Day Range:
$24.28
$25.11
1-Week Range:
$23.23
$25.90
52-Week Range:
$16.10
$28.75
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
24.88 | 1.93B | 1.29B | 58.52M | 191.78M | 0.6528 |
UNH
Unitedhealth Group Inc
|
388.47 | 347.35B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
93.26 | 119.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
394.69 | 84.65B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
286.24 | 74.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
307.95 | 36.46B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
[144] Progyny, Inc. SEC Filing - Stock Titan
Progyny Inc Annual Shareholders Meeting Transcript - GuruFocus
Insider Sell Alert: Mark Livingston Sells Shares of Progyny Inc (PGNY) - GuruFocus
Progyny Inc (PGNY) Stock Down 3.8% -- Now Undervalued? GF Score: 87/100 - GuruFocus
Progyny CFO Mark S. Livingston sells $211,012 of common stock By Investing.com - Investing.com Australia
Progyny CFO Mark S. Livingston sells $211,012 of common stock - Investing.com
Transcript : Progyny, Inc.Shareholder/Analyst Call - marketscreener.com
Progyny (PGNY) CFO sells 8,275 shares under Rule 10b5-1 plan - Stock Titan
Progyny (PGNY) COO Melissa Cummings sells 9,578 shares under 10b5-1 plan - Stock Titan
Progyny stock (US74340E1038): insider share sale filing puts focus on fertility benefits specialist - AD HOC NEWS
Progyny (PGNY) Stock Is Up, What You Need To Know - Yahoo Finance
Bull of the day: Progyny (PGNY) - MSN
Notice of proposed sale for PGNY (NASDAQ: PGNY) with recent RSU vesting - Stock Titan
CCORF Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Dow Theory LettersProgyny (PGNY) Stock Is Up, What You Need To Know - FinancialContent
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga
PGNY Upgraded by Canaccord Genuity -- Price Target Raised to $30 - GuruFocus
Canaccord upgrades Progyny stock rating to buy on guidance beat streak - Investing.com Nigeria
Canaccord Genuity Upgrades Progyny to Buy From Hold, Adjusts PT to $30 From $19 - Moomoo
Canaccord upgrades Progyny stock rating to buy on guidance beat streak By Investing.com - Investing.com South Africa
Responsive Playbooks and the PGNY Inflection - Stock Traders Daily
Canaccord Genuity upgrades Progyny (PGNY) - MSN
Progyny Is Maintained at Overweight by Barclays - Moomoo
Progyny (PGNY) Stock Forecast & Analyst Ratings - Moomoo
Progyny and Standex International have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
Bull of the Day: Progyny (PGNY) - InteractiveCrypto
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
US proposes rule for employer-sponsored fertility benefits - MSN
Progyny stock (US74340E1038): fertility benefits specialist back in focus after strong quarterly update - facilitiesmanagement-now.com
Progyny, Inc. $PGNY Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Progyny stock (US74340E1038): fertility benefits specialist back in focus after strong quarterly upd - AD HOC NEWS
The Strong Earnings Posted By Progyny (NASDAQ:PGNY) Are A Good Indication Of The Strength Of The Business - Sahm
Fertility benefits growth and share buybacks keep Progyny (PGNY) earnings in focus - MSN
Progyny stock (US74340E1038): fertility benefits specialist back in focus after latest business upda - AD HOC NEWS
Shareholders Will Be Pleased With The Quality of Progyny's (NASDAQ:PGNY) Earnings - Yahoo Finance
Progyny Q1 earnings call highlights - MSN
Progyny Inc (NASDAQ:PGNY): A GARP Play with Balanced Growth and Valuation - ChartMill
Progyny (PGNY) Q1 Earnings and Revenues Beat Estimates - Eastern Progress
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Progyny, Inc. $PGNY Shares Bought by First Eagle Investment Management LLC - MarketBeat
BofA Securities Maintains Progyny(PGNY.US) With Buy Rating - Moomoo
151,931 Shares in Progyny, Inc. $PGNY Purchased by Simcoe Capital LLC - MarketBeat
Progyny (PGNY) Q1 2026 Earnings Call Transcript - AOL.com
Proposed Rule Could Impact Fertility Benefits for Progyny (PGNY) - GuruFocus
Why Is Progyny (PGNY) Stock Soaring Today - Yahoo Finance
Progyny (PGNY) Sees Opportunities Amid New Fertility Benefits Pr - GuruFocus
Transcript : Progyny, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 11 - marketscreener.com
Progyny - Crain's New York
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $30 - Moomoo
U.S. calls for employer-sponsored fertility benefits (PGNY) - Seeking Alpha
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.12%
2.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):